These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27169737)

  • 41. Sarcoplasmic Reticulum Ca
    Du Y; Demillard LJ; Ren J
    Biochem Pharmacol; 2022 Jun; 200():115059. PubMed ID: 35490731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.
    Jung CB; Moretti A; Mederos y Schnitzler M; Iop L; Storch U; Bellin M; Dorn T; Ruppenthal S; Pfeiffer S; Goedel A; Dirschinger RJ; Seyfarth M; Lam JT; Sinnecker D; Gudermann T; Lipp P; Laugwitz KL
    EMBO Mol Med; 2012 Mar; 4(3):180-91. PubMed ID: 22174035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
    Savio-Galimberti E; Knollmann BC
    PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
    Hwang HS; Hasdemir C; Laver D; Mehra D; Turhan K; Faggioni M; Yin H; Knollmann BC
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):128-35. PubMed ID: 21270101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delayed afterdepolarization-induced triggered activity in cardiac purkinje cells mediated through cytosolic calcium diffusion waves.
    Shah C; Jiwani S; Limbu B; Weinberg S; Deo M
    Physiol Rep; 2019 Dec; 7(24):e14296. PubMed ID: 31872561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation.
    Voigt N; Li N; Wang Q; Wang W; Trafford AW; Abu-Taha I; Sun Q; Wieland T; Ravens U; Nattel S; Wehrens XH; Dobrev D
    Circulation; 2012 May; 125(17):2059-70. PubMed ID: 22456474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.
    Zhang J; Chen B; Zhong X; Mi T; Guo A; Zhou Q; Tan Z; Wu G; Chen AW; Fill M; Song LS; Chen SR
    Biochem J; 2014 Jul; 461(1):99-106. PubMed ID: 24758151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ca2+-dependent modulation of voltage-gated myocyte sodium channels.
    Salvage SC; Habib ZF; Matthews HR; Jackson AP; Huang CL
    Biochem Soc Trans; 2021 Nov; 49(5):1941-1961. PubMed ID: 34643236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
    PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation-linked, excessively tight interaction between the calmodulin binding domain and the C-terminal domain of the cardiac ryanodine receptor as a novel cause of catecholaminergic polymorphic ventricular tachycardia.
    Nishimura S; Yamamoto T; Nakamura Y; Kohno M; Hamada Y; Sufu Y; Fukui G; Nanno T; Ishiguchi H; Kato T; Xu X; Ono M; Oda T; Okuda S; Kobayashi S; Yano M
    Heart Rhythm; 2018 Jun; 15(6):905-914. PubMed ID: 29427818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice.
    Ho HT; Thambidorai S; Knollmann BC; Billman GE; Györke S; Kalyanasundaram A
    Heart Rhythm; 2018 Mar; 15(3):430-441. PubMed ID: 29030236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternating membrane potential/calcium interplay underlies repetitive focal activity in a genetic model of calcium-dependent atrial arrhythmias.
    Lou Q; Belevych AE; Radwański PB; Liu B; Kalyanasundaram A; Knollmann BC; Fedorov VV; Györke S
    J Physiol; 2015 Mar; 593(6):1443-58. PubMed ID: 25384790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT.
    Blackwell DJ; Faggioni M; Wleklinski MJ; Gomez-Hurtado N; Venkataraman R; Gibbs CE; Baudenbacher FJ; Gong S; Fishman GI; Boyle PM; Pfeifer K; Knollmann BC
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular basis of catecholaminergic polymorphic ventricular tachycardia.
    Györke S
    Heart Rhythm; 2009 Jan; 6(1):123-9. PubMed ID: 19121813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes.
    Yang Z; Ikemoto N; Lamb GD; Steele DS
    Cardiovasc Res; 2006 Jun; 70(3):475-85. PubMed ID: 16624262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.
    van Oort RJ; McCauley MD; Dixit SS; Pereira L; Yang Y; Respress JL; Wang Q; De Almeida AC; Skapura DG; Anderson ME; Bers DM; Wehrens XH
    Circulation; 2010 Dec; 122(25):2669-79. PubMed ID: 21098440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormal propagation of calcium waves and ultrastructural remodeling in recessive catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Denegri M; Dun W; Boncompagni S; Lodola F; Protasi F; Napolitano C; Boyden PA; Priori SG
    Circ Res; 2013 Jul; 113(2):142-52. PubMed ID: 23674379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.